J. Brunner

Differences in the metabolism and pharmacokinetics of two structurally similar PPAR agonists in dogs: involvement of taurine conjugation

M. S. Kim, Z. Wang, S. Wang, 2004, Xenobiotica; the fate of foreign compounds in biological systems.

Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK).

A. Boddy, S. Leyvraz, C. Sessa, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Interconversion Pharmacokinetics of Simvastatin and its Hydroxy Acid in Dogs: Effects of Gemfibrozil

T. Prueksaritanont, Y. Qiu, K. Michel, 2005, Pharmaceutical Research.

INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY

A. D. Rodrigues, T. Baillie, T. Rushmore, 2005, Drug Metabolism and Disposition.

Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.

A. D. Rodrigues, Wei Yang Lu, P. Lu, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Simultaneous determination of urinary free cortisol and 6beta-hydroxycortisol by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction.

A. D. Rodrigues, C. Tang, I. Mcintosh, 2000, Journal of chromatography. B, Biomedical sciences and applications.

EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE

M. P. Baker, T. Baillie, J. Vogel, 2004, Drug Metabolism and Disposition.

An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue.

J. Stenken, D. Musson, Jamie J. Zhao, 2008, Analytical biochemistry.

METABOLISM AND DISPOSITION OF A POTENT GROUP II METABOTROPIC GLUTAMATE RECEPTOR AGONIST, IN RATS, DOGS, AND MONKEYS

A. Nakazato, Merryl D. Cramer, J. James, 2005, Drug Metabolism and Disposition.

INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KDR KINASE: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY

A. D. Rodrigues, Catherine, T. Baillie, 2005 .